QF-PCR and maternal cell contamination
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
- Detection of MCC by QF-PCR.
- The benefit a QF-PCR based approach has over other methods.
- Best practices for handling heavily blood-stained AF samples.
Get access to the paper by filling out the form below
QF-PCR and maternal cell contamination
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
- Detection of MCC by QF-PCR.
- The benefit a QF-PCR based approach has over other methods.
- Best practices for handling heavily blood-stained AF samples.
Related content
View allDevyser Diagnostics AB publishes quarterly report for the period April to June 2024
“Devyser continued to report high sales growth in the second quarter. Organic growth compared with...
Read More
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
Read More
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
Read More